Phase II study of fludarabine phosphate (NSC 312887) in patients with advanced cervical cancer: A southwest oncology group study

D. D. Von Hoff, S. Green, E. A. Surwit, E. V. Hannigan, D. S. Alberts

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of fludarabine phosphate (NSC 312887) in patients with advanced cervical cancer: A southwest oncology group study'. Together they form a unique fingerprint.

Medicine & Life Sciences